Postpartum Vaccines and Contraception Integration for Birth Control
(PIVoT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method of combining family planning with infant vaccinations to help new mothers in rural areas access birth control more easily. The study will test whether providing family planning advice and contraception during baby vaccination visits improves postpartum contraceptive use. Mothers who recently had a baby within the last 12 weeks, speak Marathi, live in rural Maharashtra, and haven't undergone certain medical procedures like sterilization or immediate post-birth IUD placement may qualify for this trial. As an unphased trial, this study offers a unique opportunity to contribute to innovative healthcare solutions for new mothers in rural communities.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that this program is safe for postpartum women?
Research has shown that combining vaccines and birth control in postpartum care can be safe and effective. Successful methods empower women, helping them make informed choices about family planning. This approach has succeeded in communities without causing major side effects.
Although specific safety data for the PIVoT program is not available, similar methods have been well-received. These programs aim to remove obstacles and make family planning easier and more accessible, especially in resource-limited areas. This suggests that the PIVoT program is likely safe, as it builds on these proven methods.12345Why are researchers excited about this trial?
Researchers are excited about the PIVoT approach because it integrates postpartum contraception with infant vaccination through gender-transformative family planning. Unlike the standard of care, which typically separates infant vaccination from family planning support, PIVoT combines these crucial services at a single point. This integration can potentially improve access to contraception for new mothers, making it easier and more convenient for them to manage family planning. By using this combined approach, PIVoT aims to empower women with more immediate and practical options for birth control, which could lead to better health outcomes for both mothers and their infants.
What evidence suggests that the Postpartum Integration of Vaccines and Contraception Through Gender-Transformative Programming (PIVoT) is effective for postpartum contraceptive use?
This trial will compare the PIVoT approach with standard care. Studies have shown that combining family planning services with infant vaccination visits helps new mothers use birth control more effectively after giving birth. In this trial, the PIVoT approach offers family planning advice during regular baby vaccine appointments. Research indicates that this method can overcome gender-related barriers, making it easier for women to accept and use contraceptives after childbirth. Successful pilot programs have demonstrated that this integration helps more women in low-resource areas access and use birth control. By offering these services together, PIVoT aims to provide a smooth and effective way to support new mothers in planning their families.13678
Who Is on the Research Team?
Sarah Averbach, MD, MAS
Principal Investigator
University of California, San Diego
Shahina Begum, PhD
Principal Investigator
Indian Council of Medical Research-National Institute for Research in Reproductive and Child Health
Are You a Good Fit for This Trial?
This trial is for postpartum women who speak Marathi, delivered a baby within the last 8 weeks, live in rural Maharashtra, and have not had sterilization or certain immediate post-birth contraceptive procedures. Pregnant women cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive gender-transformative family planning counseling and contraception provision at the time of infant vaccination
Follow-up
Participants are monitored for contraceptive use and intervention feasibility, acceptability, and appropriateness
Qualitative Evaluation
In-depth interviews with participants, their husbands, and health care providers to evaluate the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Postpartum Integration of Vaccines and Contraception Through Gender-Transformative Programming(PIVoT)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Diego
Lead Sponsor
Indian Council of Medical Research
Collaborator